$280 Million is the total value of Anson Funds Management LP's 15 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 88.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TLRY | New | TILRAY INC | $202,334,000 | – | 1,408,812 | +100.0% | 72.27% | – |
| AMZN | AMAZON COM INCput | $24,036,000 | +17.8% | 12,000 | 0.0% | 8.58% | -28.2% | |
| NVDA | Sell | NVIDIA CORPput | $23,915,000 | -19.4% | 85,100 | -32.1% | 8.54% | -50.9% |
| UBNT | UBIQUITI NETWORKS INCput | $14,236,000 | +16.7% | 144,000 | 0.0% | 5.08% | -28.9% | |
| AMRWW | ALTA MESA RES INC*w exp 03/28/202 | $2,600,000 | -38.6% | 622,006 | 0.0% | 0.93% | -62.6% | |
| EYESW | SECOND SIGHT MED PRODS INC*w exp 03/06/202 | $2,538,000 | +14.5% | 1,335,561 | 0.0% | 0.91% | -30.3% | |
| AMRQQ | Buy | ALTA MESA RES INCcl a | $2,508,000 | -36.0% | 600,000 | +4.3% | 0.90% | -61.0% |
| CATS | New | CATASYS INC | $2,236,000 | – | 174,015 | +100.0% | 0.80% | – |
| ATAX | New | AMERICA FIRST MULTIFAMILY INben unit ctf | $1,625,000 | – | 1,250,000 | +100.0% | 0.58% | – |
| PAVMZ | New | PAVMED INC*w exp 04/30/202 | $1,462,000 | – | 1,124,541 | +100.0% | 0.52% | – |
| SHIPW | SEANERGY MARITIME HLDGS CORP*w exp 11/10/202 | $1,289,000 | +4.0% | 1,432,500 | 0.0% | 0.46% | -36.6% | |
| SSYS | New | STRATASYS LTD | $473,000 | – | 100,000 | +100.0% | 0.17% | – |
| CYTXZ | New | CYTORI THERAPEUTICS INC*w exp 05/28/202 | $421,000 | – | 1,038,600 | +100.0% | 0.15% | – |
| RXIIW | RXI PHARMACEUTICALS CORP NEW*w exp 12/16/202 | $255,000 | -39.4% | 218,023 | 0.0% | 0.09% | -63.2% | |
| NSPRZ | INSPIREMD INC*w exp 03/14/202 | $55,000 | -11.3% | 250,000 | 0.0% | 0.02% | -44.4% | |
| INPX | Exit | INPIXON | $0 | – | -181,624 | -100.0% | -0.02% | – |
| IMUCW | Exit | IMMUNOCELLULAR THERAPEUTICS*w exp 08/12/202 | $0 | – | -117,187 | -100.0% | -0.02% | – |
| NSPR | Exit | INSPIREMD INC | $0 | – | -369,774 | -100.0% | -0.05% | – |
| NVIV | Exit | INVIVO THERAPEUTICS HLDGS CO | $0 | – | -54,450 | -100.0% | -0.06% | – |
| ATOS | Exit | ATOSSA GENETICS INC | $0 | – | -108,977 | -100.0% | -0.14% | – |
| CVM | Exit | CEL SCI CORP | $0 | – | -336,500 | -100.0% | -0.18% | – |
| GNUS | Exit | GENIUS BRANDS INTL INC | $0 | – | -200,000 | -100.0% | -0.24% | – |
| ACST | Exit | ACASTI PHARMA INCcl a new | $0 | – | -684,600 | -100.0% | -0.31% | – |
| SMSI | Exit | SMITH MICRO SOFTWARE INC | $0 | – | -571,312 | -100.0% | -0.77% | – |
| CEF | Exit | SPROTT PHYSICAL GOLD & SILVEtr unit | $0 | – | -120,000 | -100.0% | -0.88% | – |
| STKS | Exit | THE ONE GROUP HOSPITALITY IN | $0 | – | -828,551 | -100.0% | -1.18% | – |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -30,000 | -100.0% | -1.73% | – |
| TAC | Exit | TRANSALTA CORP | $0 | – | -525,000 | -100.0% | -2.03% | – |
| GOLD | Exit | RANDGOLD RES LTDadr | $0 | – | -50,000 | -100.0% | -2.26% | – |
| DXJ | Exit | WISDOMTREE TRjapn hedge eqt | $0 | – | -86,000 | -100.0% | -2.72% | – |
| GG | Exit | GOLDCORP INC NEW | $0 | – | -392,125 | -100.0% | -3.91% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -251,000 | -100.0% | -39.91% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 24 | Q3 2023 | 15.9% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
| GRANITE REAL ESTATE INVT TR | 15 | Q3 2023 | 1.3% |
| BROOKFIELD ASSET MGMT INC | 15 | Q3 2022 | 1.3% |
| CENTRAL FD CDA LTD | 14 | Q1 2018 | 1.6% |
| MEI PHARMA INC | 14 | Q1 2023 | 1.2% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Appreciate Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Equity Distribution Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| GO Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| LogicMark, Inc. | February 14, 2023 | 987,399 | 9.9% |
| Model Performance Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
| Mudrick Capital Acquisition Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| View, Inc. | February 14, 2023 | 24,597,185 | 9.9% |
| Amarantus Bioscience Holdings, Inc. | April 18, 2022 | 14,176,424 | 5.0% |
| Dune Acquisition Corp | February 11, 2022 | 100,000 | 0.6% |
| PROPTECH INVESTMENT CORP. II | February 11, 2022 | 1,184,276 | 5.2% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.